Ensysce Biosciences Inc (ENSC)

0.22 -0.02 (-9.75%)
Real-time Cboe USD Disclaimer

ENSC Financial Summary

Ensysce Biosciences, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported net loss was USD 7.9 million compared to USD 0.935544 million a year ago. Basic loss per share from continuing operations was USD 0.24 compared to USD 0.06 a year ago.For the six months, net loss was USD 8.85 million compared to USD 1.88 million a year ago. Basic loss per share from continuing operations was USD 0.32 compared to USD 0.12 a year ago.
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
ENSC
Gross margin TTM -236.16%
Operating margin TTM -843.28%
Net Profit margin TTM -988.53%
Return on Investment TTM 0%
Total Revenue
Net Income
Title
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Total Revenue 0.21 0.60 1.64 1.20
Gross Profit -5.04
Operating Income -7.06 -6.51 -1.66 -16.89
Net Income -7.90 -0.95 -10.04 -17.16
Clear All
0Selected
Please try another search
ENSC
Quick Ratio MRQ 0.49
Current Ratio MRQ 0.87
LT Debt to Equity MRQ -
Total Debt to Equity MRQ -542.51%
Total Assets
Total Liabilities
Title
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Total Assets 7.95 12.37 16.42 9.72
Total Liabilities 8.75 10.98 24.30 9.82
Total Equity -0.80 1.39 -7.88 -0.11
Clear All
0Selected
Please try another search
ENSC
Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow -53.82%
Cash
Net Change in Cash
Title
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Cash From Operating Activities -4.44 -3.44 -8.24 -4.47
Cash From Investing Activities 0 0
Cash From Financing Activities -0.27 -0.39 20.31 11.13
Net Change in Cash -4.71 -3.82 12.07 6.65
Clear All
0Selected
Please try another search

* In Millions of USD (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.